Market Tracker

04/28 5:16pm ET

Depomed Inc (NASDAQ:DEPO)

11.99
Delayed Data
As of Apr 28
 -0.16 / -1.32%
Today’s Change
11.34
Today|||52-Week Range
27.02
-33.46%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close12.15
Today’s open12.15
Day’s range11.88 - 12.34
Volume680,036
Average volume (3 months)1,578,831
Market cap$744.6M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-15.08%
Earnings growth (this year)+41.48%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)+33.02%
P/E ratioNM
Price/Sales2.42
Price/Book2.96

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.60+3.86%
ACRSAclaris Therapeutics...-0.71-2.46%
MGNXMacroGenics Inc-0.14-0.64%
HSKAHeska Corp+3.03+2.88%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.11
Annual revenue (last year)$455.9M
Annual profit (last year)-$88.7M
Net profit margin-19.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts